NOVOCURE LTD's ticker is and the CUSIP is G6674U958. A total of 6 filers reported holding NOVOCURE LTD in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,115,965 | -93.2% | 69,100 | -82.6% | 0.00% | -100.0% |
| Q2 2023 | $16,463,050 | +69.1% | 396,700 | +145.0% | 0.01% | +50.0% |
| Q1 2023 | $9,736,666 | -0.4% | 161,900 | +21.5% | 0.00% | -20.0% |
| Q4 2022 | $9,777,555 | +51.6% | 133,300 | +57.0% | 0.01% | +66.7% |
| Q3 2022 | $6,451,000 | +78.8% | 84,900 | +63.6% | 0.00% | +50.0% |
| Q2 2022 | $3,607,000 | – | 51,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PURA VIDA INVESTMENTS, LLC | 64,100 | $7,446,000 | 0.23% |
| GROUP ONE TRADING, L.P. | 100,100 | $11,629,000 | 0.01% |
| HBK INVESTMENTS L P | 18,000 | $2,091,000 | 0.01% |
| SIMPLEX TRADING, LLC | 10,700 | $2,030,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 1,000 | $116,000 | 0.00% |